3D Cardiovascular Cartography

3D Cardiovascular Cartography (3D CCG) is a cutting-edge, non-invasive diagnostic technology based on Trans-Aortic Signal Wave Modulation (TASWM) and Flow Turbulence Accelometry (FTA) — collectively known as the Vertical Acceleration Detector. This innovative method generates a comprehensive physiological profile of the cardiovascular system, evaluating more than 64 functional parameters, which significantly enhance the accuracy of diagnosis.

One of its key capabilities is the measurement of blood flow to various regions of the heart. A significant reduction in blood flow detected by this system often indicates the presence of vascular obstructions. Remarkably, this technology can identify blood flow reductions due to blockages as small as 3%.

Beyond detecting blockages, the 3D CCG scan can assess:

  • Arterial stiffness (arrhythmogenicity)
  • Clotting tendency (thrombogenicity)
  • Overall stress or workload on the heart

More crucial than simply identifying blockages is understanding how well blood is actually flowing through the coronary arteries. This is because the extent of blockage does not always correlate with clinical symptoms. Instead, the degree of blood flow reduction is a more accurate indicator of heart health.

This is especially relevant due to the presence of the body’s natural backup system — known as collateral blood flow or natural bypasses — which can develop over time in individuals with severe blockages. The 3D CCG scan evaluates the Collateral Flow Index, which measures the heart’s ability to form these natural bypass channels.

In summary:

  • A patient with significant blockages but a high Collateral Flow Index may have a lower risk of heart attack or sudden cardiac death.
  • Conversely, a patient with reduced blood flow and a low capacity for natural bypass formation is at higher risk.

Understanding the functional capacity and blood flow dynamics of the heart is far more valuable than merely knowing the percentage of blockage. The 3D CCG scan empowers early detection, individualized risk assessment, and better clinical decision-making.

3D CCG, The most comprehensive functional physiology study provides:

  • Stroke Volume
  • Cardiac Out Put
  • Cardiac Index
  • Contractility
  • Acceleration of Blood Ejected
  • Pre – Load
  • After – Load
  • Blood Pressure
  • Mean Blood Pressure
  • LV Ejection Rate
  • LV Ejection Fraction
  • LV Regurgitate Fraction
  • Left Cardiac Work
  • All Systolic and Diastolic Timings
  • Electromechanical Activities
  • ANS Predominance
  • Pulmonary Air Retention
  • Pulmonary Fluid Retention
  • Pulmonary Vascular Resistance
  • Global Myocardial Blood Flow
  • Regional Myocardial Blood Flow
  • Mean Coronary Driving Pressure
  • Global Cardiac Efficiency
  • Left Ventricular Stroke Work
  • Collateral Flow Index
  • Coronary Vasodilators Reserve
  • Pressure Volume Loop
  • Mitral Valve Orifice Area
  • Aortic Valve Orifice Area
  • Angular Frequency of Heart
  • Angular Frequency of Inter-beat-interval
  • Early After Depolarisation
  • Delayed After Depolarisation
  • Arrhythmogenecity
  • Thrombus Formation Factor
  • Arterial Compliance
  • Ventricular Compliance
  • Total Myocardial Burden
  • Left Ventricular Relaxibility
  • Adrenergic Activity
  • Hypertension Analysis
  • Hypertrophy Analysis
  • Regional Effective Coronary Narrowing Index
  • Body Fat Mass
  • Basal Metabolic Rate
  • Systemic Vascular Resistance
  • Systemic Vascular Index
  • Mean Arterial Blood Pressure
  • Heart Rate
  • R R Interval
  • Myocardial Oxygen Consumption and Minute Work
  • Myocardial Oxygen Demand and Supply
  • Jeopardy of Myocardium
  • Cardiac Minute Work
  • Maximal Coronary Flow
  • Myocardial Tissue Volume
  • Average Capillary Surface Area
  • Volume Burden
  • Pressure Burden
  • Ischemic Burden
  • Global Blood Flow Deficiency Index
  • Coronary Vasodilator Reserve
  • Systolic Time Interval
  • Stroke Index

Advantages of 3D Cardiovascular Cartography

  • The first and most important advantage is early detection of Coronary Artery Diseases in asymptomatic subjects – AMONG ONE OF THE MOST ACCURATE METHODS TO DETECT EARLY CORONARY ARTERY DISEASES.
  • Reliable detection of CAD ( Coronary Artery Disease)and its severity.
  • Understanding underlying causes of chest pain in the absence of CAD.
  • Forecast signal of myocardial ischemia, prior to development of angina.
  • Establishing ANS activity.
  • Establishing thrombogenicity in cardiac patients
  • Establishing arrhythmogenicity.
  • Establish proneness to Sudden Cardiac Death Syndrome (SCDAS).
  • Measurement of Arterial elasticity, endothelial function and progression of atherosclerotic processes.
  • Measurement of ventricular elasticity and diastolic stretch in hypertrophy.
  • Early detection of pulmonary oedema, before the development of clinical symptoms.
  • Early detection of COPD, its progression and effect of Ayurvedic treatment.
  • Aids in decision making in choosing the line of management in Ayurveda.
  • Follow-up functional effectiveness during Ayurvedic treatment.
  • Establishment of pliability of Mitral and Aortic valves, in Valvular Heart Diseases.
  • Can be repeated any number of times unlike the invasive methods, and hence the effectiveness of cardiac treatments can be assessed easily and regularly